Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Resistencia bacteriana a los medicamentos"'
Autor:
Beltrán-Higuera, Sandra Jaqueline, Palacios-Ariza, María Alejandra, Mancera-Gutiérrez, Luz Angela, Velandia-Páez, Jessica Paola, Camacho-Moreno, Germán, Ortiz-Mendez, Cesar Alfredo, Rojas-Rojas, Diana Paola, Romero-Higuera, Laura Natalia, Gómez-Cortés, Leydi Cristina, Vásquez-Hoyos, Pablo, Sosa-Rodríguez, Yeni Andrea, Brand-López, Katherine, Gutiérrez, Iván Felipe, Camacho-Cruz, Jhon, Wilches Cuadros, María Angélica, Hernandez-Vargas, Juan Camilo
Publikováno v:
Magill SS, O’Leary E, Janelle SJ, et al; Emerging Infections Program Hospital Prevalence Survey Team. Changes in prevalence of health careassociated infections in U.S. hospitals. N Engl J Med. 2018;379:1732–1744.
Tong SY, Davis JS, Eichenberger E, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603–661.
Zervou FN, Zacharioudakis IM, Ziakas PD, et al. MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis. Pediatrics. 2014;133:e1015–e1023.
Senthilkumar K, Biswal N, Sistla S. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in children. Indian Pediatr. 2015;52:31–33.
David MZ, Daum RS. Update on epidemiology and treatment of MRSA infections in children. Curr Pediatr Rep. 2013;1:170–181.
Gerber JS, Coffin SE, Smathers SA, et al. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children’s hospitals in the United States. Clin Infect Dis. 2009;49:65–71.
European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net)-Annual Epidemiological Report 2019. Stockholm: ECDC; 2020. Available at: https://www.ecdc.europa. eu/sites/default/files/documents/surveillance-antimicrobial-resistanceEurope-2019.pdf. Accessed November 30, 2020.
Sutter DE, Milburn E, Chukwuma U, et al. Changing susceptibility of Staphylococcus aureus in a US pediatric population. Pediatrics. 2016;137:e20153099.
Song X, Cogen J, Singh N. Incidence of methicillin-resistant Staphylococcus aureus infection in a children’s hospital in the Washington metropolitan area of the United States, 2003-2010. Emerg microbes & infect. 2013;2:e69.
Sáenz Moncaleano V. Boletín Informativo: resultados de la vigilancia de la resistencia bacteriana Año 2018 componente pediátrico y adulto. Universidad Nacional de Colombia; 2018:26.
Márquez-Ortiz RA, Álvarez-Olmos MI, Escobar Pérez JA, et al; Research Group of Pediatric Infectious Diseases. USA300-related methicillin-resistant Staphylococcus aureus clone is the predominant cause of community and hospital MRSA infections in Colombian children. Int J Infect Dis. 2014;25:88–93.
Rojo P, Barrios M, Palacios A, et al. Community-associated Staphylococcus aureus infections in children. Expert Rev Anti Infect Ther. 2010;8:541–554.
John CC, Schreiber JR. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus. Pediatr Clin North Am. 2006;53:699–713.
Mejer N, Westh H, Schonheyder HC, et al. Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008. BMC infectious diseases. 2012;12:260
Klieger SB, Vendetti ND, Fisher BT, et al. Staphylococcus aureus bacteremia in hospitalized children: incidence and outcomes. Infect Control Hosp Epidemiol. 2015;36:603–605.
Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002;21:910–917.
Davis WT, Gilbert SR. Comparison of methicillin-resistant versus Susceptible Staphylococcus aureus pediatric osteomyelitis. J Pediatr Orthop. 2018;38:e285–e291.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Tong SY, Davis JS, Eichenberger E, et al. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin Microbiol Rev. 2015;28:603–661.
Zervou FN, Zacharioudakis IM, Ziakas PD, et al. MRSA colonization and risk of infection in the neonatal and pediatric ICU: a meta-analysis. Pediatrics. 2014;133:e1015–e1023.
Senthilkumar K, Biswal N, Sistla S. Risk factors associated with methicillin-resistant Staphylococcus aureus infection in children. Indian Pediatr. 2015;52:31–33.
David MZ, Daum RS. Update on epidemiology and treatment of MRSA infections in children. Curr Pediatr Rep. 2013;1:170–181.
Gerber JS, Coffin SE, Smathers SA, et al. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children’s hospitals in the United States. Clin Infect Dis. 2009;49:65–71.
European Centre for Disease Prevention and Control. Antimicrobial resistance in the EU/EEA (EARS-Net)-Annual Epidemiological Report 2019. Stockholm: ECDC; 2020. Available at: https://www.ecdc.europa. eu/sites/default/files/documents/surveillance-antimicrobial-resistanceEurope-2019.pdf. Accessed November 30, 2020.
Sutter DE, Milburn E, Chukwuma U, et al. Changing susceptibility of Staphylococcus aureus in a US pediatric population. Pediatrics. 2016;137:e20153099.
Song X, Cogen J, Singh N. Incidence of methicillin-resistant Staphylococcus aureus infection in a children’s hospital in the Washington metropolitan area of the United States, 2003-2010. Emerg microbes & infect. 2013;2:e69.
Sáenz Moncaleano V. Boletín Informativo: resultados de la vigilancia de la resistencia bacteriana Año 2018 componente pediátrico y adulto. Universidad Nacional de Colombia; 2018:26.
Márquez-Ortiz RA, Álvarez-Olmos MI, Escobar Pérez JA, et al; Research Group of Pediatric Infectious Diseases. USA300-related methicillin-resistant Staphylococcus aureus clone is the predominant cause of community and hospital MRSA infections in Colombian children. Int J Infect Dis. 2014;25:88–93.
Rojo P, Barrios M, Palacios A, et al. Community-associated Staphylococcus aureus infections in children. Expert Rev Anti Infect Ther. 2010;8:541–554.
John CC, Schreiber JR. Therapies and vaccines for emerging bacterial infections: learning from methicillin-resistant Staphylococcus aureus. Pediatr Clin North Am. 2006;53:699–713.
Mejer N, Westh H, Schonheyder HC, et al. Stable incidence and continued improvement in short term mortality of Staphylococcus aureus bacteraemia between 1995 and 2008. BMC infectious diseases. 2012;12:260
Klieger SB, Vendetti ND, Fisher BT, et al. Staphylococcus aureus bacteremia in hospitalized children: incidence and outcomes. Infect Control Hosp Epidemiol. 2015;36:603–605.
Sattler CA, Mason EO Jr, Kaplan SL. Prospective comparison of risk factors and demographic and clinical characteristics of community-acquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002;21:910–917.
Davis WT, Gilbert SR. Comparison of methicillin-resistant versus Susceptible Staphylococcus aureus pediatric osteomyelitis. J Pediatr Orthop. 2018;38:e285–e291.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Antecedentes: La epidemiología de Staphylococcus aureus resistente a la meticilina (MRSA) y S. aureus sensible a la meticilina (MSSA) ha cambiado en los últimos años. El presente artículo tiene como objetivo establecer las diferencias entre los h
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1bbf5ea7eb38df6d63eddeeba4ea435f
https://repository.urosario.edu.co/handle/10336/37949
https://repository.urosario.edu.co/handle/10336/37949
Autor:
Lucila Gómez Rodríguez, Amelec Jesus Viloria Silva, Alexander Parody Muñoz, Myrna Campo Urbina
Publikováno v:
REDICUC-Repositorio CUC
Corporación Universidad de la Costa
instacron:Corporación Universidad de la Costa
Corporación Universidad de la Costa
instacron:Corporación Universidad de la Costa
Objectives: To determine the trend of bacterial resistance of Escherichia coli to Imipenem (IPM) and Meropenem (MEM), by means of a linear regression model, taking the information collected in the bulletins of bacterial resistance generated by the GR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2088cf78dd1a9ecb5638285f96a9db8
https://repositorio.cuc.edu.co/
https://repositorio.cuc.edu.co/
Autor:
de Oliveira Bandeira, Eliel, Gautério Abreu, Daiane Porto, Piveta de Lima, Juliana, Silva da Costa, Cesar Francisco, Rodrigues da Costa, Aline, Fernandes Martins, Nidia Farias
Publikováno v:
Revista de Pesquisa: Cuidado é Fundamental; Jan-Mar2019, Vol. 11 Issue 1, p1-10, 10p
Autor:
Aljure, Jorge Raad
Publikováno v:
Revista Mexicana de Patologia Clinica. jun98, Vol. 45 Issue 2, p107. 4p. 1 Chart.
Autor:
Dr. Dale E. Bredesen
«Un libro que […] ilumina nuestra lucha en la oscuridad, ofrece un camino científico claro para terminar el azote de una enfermedad que roba la mente a millones». Doctor MarkHyman, autor de losbestsellersCome grasa y adelgaza yLa solución del a
Autor:
Stephen W. Moore
With over 430 patient instruction fact sheets and an additional 123 patient instruction sheets online, the new edition of Griffith's Instructions for Patients by Stephen W. Moore, MD, helps patients understand what their illness is, how it will affec